Literature DB >> 2508310

Immunohistochemical expression of epidermal growth factor receptor in salivary gland tumours.

K Yamada1, K Iwai, Y Okada, M Mori.   

Abstract

Immunohistochemical localization of epidermal growth factor receptor (EGFR) in normal salivary glands and tumours (108 cases) was studied using a monoclonal antibody. In the normal salivary glands, EGFR was occasionally detected in ductal segments of intercalated, striated, and excretory ducts, but not in acinar cells. The frequency of positive EGFR staining in salivary gland tumours was not high: pleomorphic adenoma, 33.8%; mucoepidermoid tumour, 25.0%; adenolymphoma, 44.4%; and sialoadenocarcinoma, 66.6%. Pleomorphic adenomas showed positive staining for EGFR on the luminal side of luminal cells and in squamous metaplastic cells of tumour tissue. Some modified myoepithelial cells were also reactive whereas outer spindle tumour cells were unstained. Adenolymphomas regularly exhibited positive EGFR staining in the cell membrane; mucoepidermoid carcinoma displayed positive staining in cell membranes in epidermoid tumour cells and cytoplasmic staining in mucous-secreting tumour cells. Sialocarcinomas revealed cell membrane staining and whole cytoplasmic staining for EGFR. The immunohistochemical localization of EGFR could be classified into two types, one the cell membrane-positive type found in epithelial tumour cells, and the second the cytoplasmic positive type seen in normal ductal cells, the luminal tumour cells of pleomorphic adenomas and mucous-secreting tumour cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2508310     DOI: 10.1007/bf00718645

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  31 in total

1.  Expression of epidermal growth factor receptor in human gastric and colonic carcinomas.

Authors:  W Yasui; H Sumiyoshi; J Hata; T Kameda; A Ochiai; H Ito; E Tahara
Journal:  Cancer Res       Date:  1988-01-01       Impact factor: 12.701

2.  Immunohistochemical localisation of urogastrone to human duodenal and submandibular glands.

Authors:  P U Heitz; M Kasper; S van Noorden; J M Polak; H Gregory; A G Pearse
Journal:  Gut       Date:  1978-05       Impact factor: 23.059

Review 3.  Biologically active polypeptides in submandibular glands.

Authors:  T Barka
Journal:  J Histochem Cytochem       Date:  1980-08       Impact factor: 2.479

4.  Elevated epidermal growth factor receptor gene copy number and expression in a squamous carcinoma cell line.

Authors:  G T Merlino; Y H Xu; N Richert; A J Clark; S Ishii; S Banks-Schlegel; I Pastan
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

5.  Growth-inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture.

Authors:  N Kamata; K Chida; K Rikimaru; M Horikoshi; S Enomoto; T Kuroki
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

6.  Epidermal growth factor receptor expression and growth fraction in human tumours of the nervous system.

Authors:  G Reifenberger; R Prior; M Deckert; W Wechsler
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

7.  Expression of epidermal growth factor receptors on normal human gastric epithelia and gastric carcinomas.

Authors:  K Sakai; S Mori; T Kawamoto; S Taniguchi; O Kobori; Y Morioka; T Kuroki; K Kano
Journal:  J Natl Cancer Inst       Date:  1986-11       Impact factor: 13.506

8.  Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.

Authors:  S L Fitzpatrick; J Brightwell; J L Wittliff; G H Barrows; G S Schultz
Journal:  Cancer Res       Date:  1984-08       Impact factor: 12.701

9.  Immunohistochemical detection of human epidermal growth factor in submandibular glands and their tumors using a polyclonal antiserum and a monoclonal antibody.

Authors:  K Tsukitani; Y Tatemoto; Y Noda; M Mori; T Hayashi; K Kato
Journal:  Histochemistry       Date:  1987

10.  Epidermal growth factor receptors in cancer tissues of esophagus, lung, pancreas, colorectum, breast and stomach.

Authors:  S Ozawa; M Ueda; N Ando; O Abe; N Shimizu
Journal:  Jpn J Cancer Res       Date:  1988-11
View more
  11 in total

1.  Subcellular localization of epidermal growth factor receptor in human submandibular gland.

Authors:  M S Lantini; M Cossu; M Isola; M Piras; M Piludu
Journal:  J Anat       Date:  2006-05       Impact factor: 2.610

2.  Species differences in the expression of transforming growth factor-alpha (TGF-alpha) in the submandibular gland and pancreas.

Authors:  Y Ikematsu; P M Pour; K Kazakoff
Journal:  Int J Pancreatol       Date:  1997-10

3.  Current role of chemotherapy in exclusive and integrated treatment of malignant tumours of salivary glands.

Authors:  G Cortesina; M Airoldi; F Palonta
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-06       Impact factor: 2.124

4.  Carcinoma ex pleomorphic adenoma of the salivary gland: an immunohistochemical study.

Authors:  Saori Matsubayashi; Toshio Yoshihara
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-02-20       Impact factor: 2.503

Review 5.  Salivary mucoepidermoid carcinoma revisited.

Authors:  Andrés Coca-Pelaz; Juan P Rodrigo; Asterios Triantafyllou; Jennifer L Hunt; Alessandra Rinaldo; Primož Strojan; Missak Haigentz; William M Mendenhall; Robert P Takes; Vincent Vander Poorten; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-26       Impact factor: 2.503

6.  Extra-cellular signal-regulated ERK-1/ERK-2 pathway activation in human salivary gland mucoepidermoid carcinoma: association to aggressive tumor behavior and tumor cell proliferation.

Authors:  Adriana Handra-Luca; Hadi Bilal; Jacques-Charles Bertrand; Pierre Fouret
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

7.  Salivary gland-type lung carcinomas: an EGFR immunohistochemical, molecular genetic, and mutational analysis study.

Authors:  Ricardo S Macarenco; Timothy S Uphoff; Heather Flynn Gilmer; Robert B Jenkins; Stephen N Thibodeau; Jean E Lewis; Julian R Molina; Ping Yang; Marie-Christine Aubry
Journal:  Mod Pathol       Date:  2008-06-27       Impact factor: 7.842

8.  Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib.

Authors:  Laura Vidal; Ming S Tsao; Gregory R Pond; Ezra E W Cohen; Roger B Cohen; Eric X Chen; Mark Agulnik; Sebastien Hotte; Eric Winquist; Scott Laurie; D Neil Hayes; James Ho; Janet Dancey; Lillian L Siu
Journal:  Head Neck       Date:  2009-08       Impact factor: 3.147

9.  Molecularly guided treatment of metastatic parotid gland carcinoma in adults.

Authors:  Hossein Taghizadeh; Leonhard Müllauer; Robert M Mader; Thorsten Füreder; Gerald W Prager
Journal:  Wien Klin Wochenschr       Date:  2020-12-09       Impact factor: 1.704

10.  PCP4/PEP19 and HER2 Are Novel Prognostic Markers in Mucoepidermoid Carcinoma of the Salivary Gland.

Authors:  Takuya Yoshimura; Shotaro Higashi; Sohsuke Yamada; Hirotsugu Noguchi; Mitsuharu Nomoto; Hajime Suzuki; Takayuki Ishida; Hirotaka Takayama; Yuka Hirano; Masaru Yamashita; Akihide Tanimoto; Norifumi Nakamura
Journal:  Cancers (Basel)       Date:  2021-12-23       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.